New COVID Variant Already the Dominant US Strain
- 8 months ago
New COVID Variant , Already the Dominant , US Strain .
The World Health Organization has
warned of a new COVID-19 strain
called EG.5, otherwise known as 'Eris.'.
CNBC reports that Eris accounts for a growing
number of cases in countries around
the world, including the United States and China.
According to the WHO, Eris is a "variant of interest"
and will be monitored for mutations
that could make it more dangerous.
The organization said that current evidence
suggests a low risk to public health at a global
level, similar to other variants currently circulating.
In May, the WHO announced that COVID was now , “an established and ongoing health issue
which no longer constitutes a public health
emergency of international concern.”.
In May, the WHO announced that COVID was now , “an established and ongoing health issue
which no longer constitutes a public health
emergency of international concern.”.
While EG.5 has shown increased prevalence,
growth advantage, and immune escape
properties, there have been no reported
changes in disease severity to date, WHO risk evaluation, via CNBC.
According to the WHO, the properties
of Eris suggest that it may become a dominant
strain, potentially around the world.
According to the WHO, the properties
of Eris suggest that it may become a dominant
strain, potentially around the world.
Data from the Global Initiative on Sharing All Influenza Data
(GISAID) suggests the largest number of Eris cases are in
China, followed by the U.S., Canada, Japan and South Korea.
Data from the Global Initiative on Sharing All Influenza Data
(GISAID) suggests the largest number of Eris cases are in
China, followed by the U.S., Canada, Japan and South Korea.
The new strain has also reportedly
been identified in Australia, Singapore,
the United Kingdom, France, Spain and Portugal.
The new strain has also reportedly
been identified in Australia, Singapore,
the United Kingdom, France, Spain and Portugal.
According to the CDC, Eris has already become
the dominant strain in the U.S., accounting
for 17.3% of all cases the week of August 5
The World Health Organization has
warned of a new COVID-19 strain
called EG.5, otherwise known as 'Eris.'.
CNBC reports that Eris accounts for a growing
number of cases in countries around
the world, including the United States and China.
According to the WHO, Eris is a "variant of interest"
and will be monitored for mutations
that could make it more dangerous.
The organization said that current evidence
suggests a low risk to public health at a global
level, similar to other variants currently circulating.
In May, the WHO announced that COVID was now , “an established and ongoing health issue
which no longer constitutes a public health
emergency of international concern.”.
In May, the WHO announced that COVID was now , “an established and ongoing health issue
which no longer constitutes a public health
emergency of international concern.”.
While EG.5 has shown increased prevalence,
growth advantage, and immune escape
properties, there have been no reported
changes in disease severity to date, WHO risk evaluation, via CNBC.
According to the WHO, the properties
of Eris suggest that it may become a dominant
strain, potentially around the world.
According to the WHO, the properties
of Eris suggest that it may become a dominant
strain, potentially around the world.
Data from the Global Initiative on Sharing All Influenza Data
(GISAID) suggests the largest number of Eris cases are in
China, followed by the U.S., Canada, Japan and South Korea.
Data from the Global Initiative on Sharing All Influenza Data
(GISAID) suggests the largest number of Eris cases are in
China, followed by the U.S., Canada, Japan and South Korea.
The new strain has also reportedly
been identified in Australia, Singapore,
the United Kingdom, France, Spain and Portugal.
The new strain has also reportedly
been identified in Australia, Singapore,
the United Kingdom, France, Spain and Portugal.
According to the CDC, Eris has already become
the dominant strain in the U.S., accounting
for 17.3% of all cases the week of August 5